Debt (Details Narrative) - USD ($)				1 Months Ended		2 Months Ended	3 Months Ended	8 Months Ended	9 Months Ended	12 Months Ended
	Dec. 16, 2024	Sep. 30, 2024	Dec. 31, 2023	Jan. 31, 2025	Dec. 31, 2024	Feb. 28, 2025	Dec. 31, 2023	Dec. 31, 2023	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Feb. 03, 2025	Oct. 11, 2023	May 03, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Long term debt					$ 28,000,000.0					$ 28,000,000.0
Long term debt availability					7,200,000					$ 7,200,000
Commitment Fee Percentage										0.50%
Fair value adjustment, SEPA					800,000						$ 39,800,000
Payments on Senior Convertible Note										$ 3,748,000
Stock issued during period value conversion of convertible securities								$ 3,209,000
Fair value of the AR debentures
Payment on subordinated note related party										1,786,000
Fair value of subordinated					4,600,000					4,600,000
Loss on adjustment to fair value debt and warrants					1,100,000					1,100,000
SBA Loan [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage			3.75%				3.75%	3.75%			3.75%
Debt [Member]
Debt Instrument [Line Items]
Fair value of the AR debentures													$ 5,800,000	$ 2,000,000.0
Loss on adjustment to fair value							$ 3,800,000
Bristol Investment Fund Ltd [Member] | Barlock [Member]
Debt Instrument [Line Items]
Debt instrument, issued, principal			$ 1,000,000.0
Barlock [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate during period			12.00%
Senior Convertible Note [Member]
Debt Instrument [Line Items]
Senior convertible note		$ 15,000,000.0							$ 15,000,000.0
Debt instrument, interest rate, stated percentage		8.00%							8.00%
Maturity date									Sep. 30, 2025
Conversion rate									105.00%
Debt instrument, issued, principal										11,300,000
Fair value of the AR debentures					12,600,000					12,600,000
Debt principal balance					1,300,000					1,300,000
Subordinated Promissory Note [Member]
Debt Instrument [Line Items]
Maturity date									Dec. 31, 2025
Debt principal balance		$ 5,000,000.0							$ 5,000,000.0
Interest rate		10.00%							10.00%
Subordinated Note [Member]
Debt Instrument [Line Items]
Debt principal balance					3,200,000					$ 3,200,000
Payment on subordinated note related party					$ 1,800,000
Warrants to purchase common stock		1,141,552			570,778				1,141,552	570,778
Credit Facility [Member]
Debt Instrument [Line Items]
Unamortized deferred financing costs					$ 1,700,000					$ 1,700,000
Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument [Line Items]
Annum interest rate adjustment percentage										0.10%
Secured Overnight Financing Rate (SOFR) [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage										3.00%
Secured Overnight Financing Rate (SOFR) [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage										4.00%
Alternate Base Rate Loans [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage										2.00%
Alternate Base Rate Loans [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage										3.00%
Subsequent Event [Member] | Senior Convertible Note [Member]
Debt Instrument [Line Items]
Stock issued during period value conversion of convertible securities						$ 11,300,000
Stock issued during period value conversion of convertible securities, shares				2,100,000
Subsequent Event [Member] | Bayswater Acquisition [Member]
Debt Instrument [Line Items]
Line of credit facility maximum borrowing capacity												$ 60,000,000.0
Reserve Based Credit Agreement [Member]
Debt Instrument [Line Items]
Long-Term Line of Credit	$ 1,000,000.0
Line of Credit Facility, Expiration Date	Dec. 16, 2026
Elected commitment					44,000,000.0					$ 44,000,000.0
Issuance of letter of credit					5,000,000.0					$ 5,000,000.0
Credit Facility Agreement [Member]
Debt Instrument [Line Items]
Debt instrument interest rate ratio										Net Leverage Ratio (as defined in the Credit Agreement) of no greater than 2.50 to 1.00 and a Current Ratio (as defined in the Credit Agreement) of at least 1.00 to 1.00. The Credit Facility Agreement also includes conditional equity cure rights that will enable the Company to cure certain breaches of these financial maintenance covenants. Further, beginning March 1, 2025, the Credit Facility Agreement requires the Company and its restricted subsidiaries to always hedge not less than 80% of projected production from their proved developed producing reserves and certain wells through December 31, 2028.
Credit Facility Agreement [Member] | Senior Convertible Note [Member]
Debt Instrument [Line Items]
Payments on Senior Convertible Note					3,700,000
Standby Equity Purchase Agreement [Member]
Debt Instrument [Line Items]
Payment to structuring fee		$ 25,000
Number of shares issued for services		100,000
Common stock conversion features		Any purchases under an Advance will be subject to certain limitations, including that Yorkville cannot acquire (i) any shares that would result in the Yorkville, including its affiliates, beneficially owning more than 4.99% of the Company’s outstanding Common Stock at the time of an Advance or (ii) more than 19.99% of the Company’s issued and outstanding Common Stock as of the SEPA Effective Date (the “Exchange Cap”), subject to limited exceptions.
Issuance of series D preferred stock, shares										100,000
Standby Equity Purchase Agreement [Member] | Maximum [Member]
Debt Instrument [Line Items]
Sale of stock									$ 40,000,000.0
SEPA Registration Rights Agreement [Member]
Debt Instrument [Line Items]
Issuance of series D preferred stock, shares		4,198,343
Borrowing from convertible debt					15,000,000.0					$ 15,000,000.0
Debt Instrument, Fair Value Disclosure					$ 800,000					$ 800,000